CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
US 简体中文
國家 • United States
    實體 • The products and services listed on this website are not available in this location.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 Ironwood - IRWD CFD

    -
    0%
    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 -
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.025457%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.003235%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    Ironwood Pharmaceuticals Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    关键数据
    前收盘价* N/A
    开仓* N/A
    1 年变化* N/A
    日范围* N/A
    52 周范围 9.73-12.66
    平均交易量（10 天） 2.82M
    平均交易量（3 个月) 51.09M
    市值 1.69B
    市盈率 10.82
    流通股 155.35M
    收入 417.13M
    EPS 1.01
    股息（收益率 %） N/A
    贝塔 0.95
    下一个财报发布日期 Aug 2, 2023

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平仓 Change Change (%) 開倉 High Low

    Ironwood Events

    时间（协调世界时） (UTC) 国家/地区 事件
    Tuesday, June 20, 2023

    时间（协调世界时） (UTC)

    13:00

    国家/地区

    US

    事件

    Ironwood Pharmaceuticals Inc Annual Shareholders Meeting
    Ironwood Pharmaceuticals Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Wednesday, August 2, 2023

    时间（协调世界时） (UTC)

    12:30

    国家/地区

    US

    事件

    Q2 2023 Ironwood Pharmaceuticals Inc Earnings Release
    Q2 2023 Ironwood Pharmaceuticals Inc Earnings Release

    Forecast

    -

    Previous

    -
    Wednesday, November 1, 2023

    时间（协调世界时） (UTC)

    12:30

    国家/地区

    US

    事件

    Q3 2023 Ironwood Pharmaceuticals Inc Earnings Release
    Q3 2023 Ironwood Pharmaceuticals Inc Earnings Release

    Forecast

    -

    Previous

    -
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 410.596 413.753 389.523 428.413 346.639
    收入 410.596 413.753 389.523 428.413 346.639
    收入成本，共计 0 0 3.136 23.875 32.751
    毛利 410.596 413.753 386.387 404.538 313.888
    总营业费用 160.259 181.494 246.583 339.267 497.309
    销售/一般/行政费用，总计 115.994 111.242 141.784 173.104 221.818
    研究与开发 44.265 70.405 88.062 115.044 101.06
    Depreciation / Amortization 0 8.111
    异常费用（收入） 0 -0.153 13.601 27.244 164.614
    Other Operating Expenses, Total 0 -31.045
    营业收入 250.337 232.259 142.94 89.146 -150.67
    利息收入（费用），非经营净值 2.085 -31.602 -34.103 -30.717 -43.476
    税前净收入 252.422 200.657 108.861 58.943 -194.146
    税后净收入 175.065 528.448 106.176 58.943 -194.146
    未计算非常项目前的净收益 175.065 528.448 106.176 58.943 -194.146
    净收入 175.065 528.448 106.176 21.505 -282.368
    普通股股东可获收益 (不含非经常性项目) 175.065 528.448 106.176 58.943 -194.146
    普通股股东可获收益 (含非經常性項目) 175.065 528.448 106.176 21.505 -282.368
    摊薄净收入 179.514 528.448 106.176 21.505 -282.368
    摊薄后加权平均股 186.312 164.418 160.655 156.023 152.634
    扣除特别项目的每股摊薄盈利 0.96351 3.21405 0.66089 0.37778 -1.27197
    每股正常摊薄盈利 0.96351 3.21345 0.74347 0.5524 -0.19348
    其他，净值 0 0 0.024 0.514 0
    非常规项目总计 0 -37.438 -88.222
    摊薄调整 4.449
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    总收入 104.061 107.199 108.637 97.231 97.529
    收入 104.061 107.199 108.637 97.231 97.529
    收入成本，共计
    毛利
    总营业费用 43.964 38.836 40.164 41.576 39.683
    销售/一般/行政费用，总计 31.117 28.39 28.619 30.124 28.861
    研究与开发 12.847 10.446 11.545 11.452 10.822
    异常费用（收入） 0 0
    营业收入 60.097 68.363 68.473 55.655 57.846
    利息收入（费用），非经营净值 5.764 3.902 1.434 -1.87 -1.381
    税前净收入 65.861 72.265 69.907 53.785 56.465
    税后净收入 45.714 48.867 50.317 37.08 38.801
    未计算非常项目前的净收益 45.714 48.867 50.317 37.08 38.801
    净收入 45.714 48.867 50.317 37.08 38.801
    普通股股东可获收益 (不含非经常性项目) 45.714 48.867 50.317 37.08 38.801
    普通股股东可获收益 (含非經常性項目) 45.714 48.867 50.317 37.08 38.801
    摊薄净收入 46.829 49.981 51.429 38.192 39.911
    摊薄后加权平均股 186.68 185.736 184.465 184.876 189.54
    扣除特别项目的每股摊薄盈利 0.25085 0.2691 0.2788 0.20658 0.21057
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    每股正常摊薄盈利 0.25085 0.2691 0.2788 0.20658 0.21057
    其他，净值
    非常规项目总计
    摊薄调整 1.115 1.114 1.112 1.112 1.11
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    流动资产总额 780.626 745.225 495.839 306.852 266.435
    现金和短期投资 656.203 620.129 362.564 177.023 173.172
    现金等价物 656.203 620.129 362.564 177.023 173.172
    短期投资 0
    应收账款总额，净额 115.458 114.042 122.351 117.246 80.95
    Accounts Receivable - Trade, Net 115.458 114.042 122.351 117.246 80.95
    Total Inventory 0.648 0
    Prepaid Expenses 7.715 8.689 9.189 10.685 11.063
    Total Assets 1100.52 1126.93 559.238 402.748 332.05
    Property/Plant/Equipment, Total - Net 20.311 22.925 25.505 30.172 17.27
    Property/Plant/Equipment, Total - Gross 31.075 32.553 37.31 40.254 82.498
    Accumulated Depreciation, Total -10.764 -9.628 -11.805 -10.082 -65.228
    Goodwill, Net 0.785 0.785
    Intangibles, Net
    Other Long Term Assets, Total 284.993 334.779 14.493 32.342 47.56
    Total Current Liabilities 25.525 161.698 32.173 40.929 119.524
    Accounts Payable 0.483 0.935 0.661 5.487 18.123
    Accrued Expenses 25.023 42.589 31.512 34.567 53.471
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 116.858 0 47.627
    Other Current Liabilities, Total 0.019 1.316 0.875 0.303
    Total Liabilities 448.141 521.016 496.598 495.999 528.421
    Total Long Term Debt 396.251 337.333 430.256 407.994 366.296
    Long Term Debt 396.251 337.333 430.256 407.994 366.138
    Capital Lease Obligations 0 0.158
    Other Liabilities, Total 26.365 21.985 34.169 47.076 42.601
    Total Equity 652.378 605.911 62.64 -93.251 -196.371
    Preferred Stock - Non Redeemable, Net 0 0 0 0
    Common Stock 0.154 0.162 0.161 0.158 0.154
    Additional Paid-In Capital 1348.6 1543.36 1528.54 1478.82 1394.6
    Retained Earnings (Accumulated Deficit) -696.376 -937.608 -1466.06 -1572.23 -1591.13
    Other Equity, Total 0
    Total Liabilities & Shareholders’ Equity 1100.52 1126.93 559.238 402.748 332.05
    Total Common Shares Outstanding 154.027 162.036 160.617 157.536 154.415
    Other Current Assets, Total 1.25 2.365 1.735 1.25 1.25
    Note Receivable - Long Term 14.589 23.998 23.401 32.597
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    流动资产总额 866.374 780.626 698.994 617.826 710.101
    现金和短期投资 740.342 656.203 574.188 504.365 593.371
    现金等价物 740.342 656.203 574.188 504.365 593.371
    应收账款总额，净额 115.749 115.458 116.545 102.357 105.515
    Accounts Receivable - Trade, Net 115.749 115.458 116.545 102.357 105.515
    Prepaid Expenses 9.033 7.715 7.011 9.854 8.537
    Other Current Assets, Total 1.25 1.25 1.25 1.25 2.678
    Total Assets 1155.28 1100.52 1040.34 975.69 1083.38
    Property/Plant/Equipment, Total - Net 19.689 20.311 21.025 21.664 22.257
    Note Receivable - Long Term 0 14.589 14.439 14.289 14.143
    Other Long Term Assets, Total 269.214 284.993 305.886 321.911 336.88
    Total Current Liabilities 23.843 25.525 27.117 23.298 147.403
    Accounts Payable 0.118 0.483 0.795 0.317 0.532
    Accrued Expenses 23.725 25.023 26.321 22.829 25.391
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 448.425 448.141 449.281 442.807 565.598
    Total Long Term Debt 396.653 396.251 395.85 395.451 395.053
    Long Term Debt 396.653 396.251 395.85 395.451 395.053
    Other Liabilities, Total 27.929 26.365 26.314 24.058 23.142
    Total Equity 706.852 652.378 591.063 532.883 517.783
    Common Stock 0.155 0.154 0.153 0.153 0.155
    Additional Paid-In Capital 1357.36 1348.6 1336.15 1328.29 1350.27
    Retained Earnings (Accumulated Deficit) -650.662 -696.376 -745.243 -795.56 -832.64
    Total Liabilities & Shareholders’ Equity 1155.28 1100.52 1040.34 975.69 1083.38
    Total Common Shares Outstanding 155.346 154.027 153.319 153.176 155.115
    Current Port. of LT Debt/Capital Leases 0 0 0 120.581
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Other Current Liabilities, Total 0 0.019 0.001 0.152 0.899
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    净收入/起跑线 175.065 528.448 106.176 21.505 -282.368
    经营活动产生的现金 273.763 261.895 168.836 10.725 -70.882
    经营活动产生的现金 1.418 1.523 3.564 5.58 6.112
    Amortization 0 8.111
    非现金物品 28.721 47.487 60.037 83.633 189.647
    已付现金利息 5.745 7.216 7.216 17.584 18.235
    营运资金的变化 2.82 17.731 -0.941 -99.993 7.616
    投资活动产生的现金 -0.136 -0.265 -1.842 -11.144 88.866
    资本支出 -0.136 -0.265 -1.842 -7.189 -8.621
    其他投资现金流量项目，总计 0 -3.955 97.487
    融资活动产生的现金 -237.553 -4.55 18.546 -1.185 30.072
    融资现金流项目 0 -9.048 -0.165
    股票的发行（报废），净额 -116.854 -4.55 18.546 -8.39 32.061
    债务的发行（退还），净额 -120.699 0 0 16.253 -1.824
    现金净变化 36.074 257.08 185.54 -1.604 48.056
    Cash Taxes Paid 4.615 3.452 1.848
    Deferred Taxes 65.739 -333.294
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 45.714 175.065 126.198 75.881 38.801
    Cash From Operating Activities 80.171 273.763 194.581 125.489 64.124
    Cash From Operating Activities 0.286 1.418 1.078 0.715 0.355
    Non-Cash Items 7.514 28.721 21.01 13.694 5.896
    Changes in Working Capital 9.605 2.82 0.685 5.605 4.364
    Cash From Financing Activities 3.981 -237.553 -240.359 -241.156 -90.873
    Issuance (Retirement) of Stock, Net 3.981 -116.854 -119.66 -120.457 -90.873
    Net Change in Cash 84.139 36.074 -45.941 -115.764 -26.758
    Deferred Taxes 17.052 65.739 45.61 29.594 14.708
    Cash From Investing Activities -0.013 -0.136 -0.163 -0.097 -0.009
    Capital Expenditures -0.013 -0.136 -0.163 -0.097 -0.009
    Other Investing Cash Flow Items, Total
    Financing Cash Flow Items
    Issuance (Retirement) of Debt, Net -120.699 -120.699 -120.699
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    BlackRock Institutional Trust Company, N.A. Investment Advisor 14.2993 22213467 -610874 2023-03-31 LOW
    Sarissa Capital Management, L.P. Hedge Fund 10.5506 16390000 0 2023-03-31
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 9.6117 14931427 222467 2023-03-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 6.7474 10481842 -697736 2023-03-31 LOW
    LSV Asset Management Investment Advisor 4.878 7577709 -348688 2023-03-31 LOW
    Renaissance Technologies LLC Hedge Fund 2.9854 4637753 263600 2023-03-31 HIGH
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 2.967 4609079 946481 2023-03-31 LOW
    Credit Suisse International Research Firm 2.5749 4000041 4000041 2023-03-31 LOW
    Brown Capital Management, LLC Investment Advisor 2.5324 3933933 -63112 2023-03-31 LOW
    Two Sigma Investments, LP Hedge Fund 2.2665 3520855 203095 2023-03-31 HIGH
    Victory Capital Management Inc. Investment Advisor/Hedge Fund 1.9507 3030332 127656 2023-03-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.6954 2633804 118514 2023-03-31 LOW
    Pacer Advisors, Inc. Investment Advisor 1.456 2261800 711756 2023-03-31 HIGH
    Jane Street Capital, L.L.C. Research Firm 1.2397 1925882 1783342 2023-03-31 HIGH
    Royce Investment Partners Investment Advisor/Hedge Fund 1.2142 1886247 210758 2023-03-31 LOW
    BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 1.1637 1807808 135157 2023-03-31 LOW
    Invesco Capital Management LLC Investment Advisor 1.0495 1630403 43855 2023-03-31 LOW
    Nuveen LLC Pension Fund 1.0332 1605096 -204093 2023-03-31 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.9795 1521628 -1530093 2022-12-31 LOW
    Charles Schwab Investment Management, Inc. Investment Advisor 0.9699 1506691 418419 2023-03-31 LOW

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    535K+

    交易者

    87K+

    每月活跃客户

    $113M+

    每月投资额

    $64M+

    每月提取金额

    交易计算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    交易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投资
    交易规模（杠杆 x 投资）：
    開倉

    平仓

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/盈利/亏损

    Ironwood Company profile

    关于 Ironwood

    Ironwood Pharmaceuticals, Inc.是一家胃肠道（GI）保健公司，专注于未满足需求领域的胃肠道产品的开发和商业化，包括便秘肠易激综合症（IBS C）和慢性特发性便秘（CIC）。 该公司在人类治疗学业务领域运营。 其候选产品LINZESS（linaclotide）在美国和墨西哥适用于患有IBS-C或CIC的成年男性和女性，以及患有IBS-C的成年男性和女性。 其利那洛肽在加拿大以商标名CONSTELLA提供给患有IBS-C或CIC的成年男性和女性，并在某些欧洲国家提供给患有IBS-C的成年男性和女性。 公司的产品管道包括IW-3300，这是一种GC-C激动剂，可能用于治疗内脏疼痛疾病，包括间质性膀胱炎/膀胱疼痛综合症和子宫内膜异位症；CNP-104是一种耐受性免疫调节纳米粒子。

    Industry: Biotechnology & Medical Research (NEC)

    100 Summer Street, Suite 2300
    BOSTON
    MASSACHUSETTS 02110
    US

    收入报表

    • Annual
    • Quarterly

    人们也观看

    BTC/USD

    26,982.95 Price
    +0.360% 1D Chg, %
    多头隔夜费 -0.0616%
    空头隔夜费 0.0137%
    隔夜费时间 21:00 (UTC)
    价差 60.00

    US100

    14,496.10 Price
    +0.270% 1D Chg, %
    多头隔夜费 -0.0255%
    空头隔夜费 0.0032%
    隔夜费时间 21:00 (UTC)
    价差 1.8

    Gold

    1,965.95 Price
    -0.690% 1D Chg, %
    多头隔夜费 -0.0183%
    空头隔夜费 0.0101%
    隔夜费时间 21:00 (UTC)
    价差 0.30

    XRP/USD

    0.52 Price
    +1.130% 1D Chg, %
    多头隔夜费 -0.0753%
    空头隔夜费 0.0069%
    隔夜费时间 21:00 (UTC)
    价差 0.00397

    还在找一位您可以信任的经纪商吗？

    加入成为全球535,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易